Pharming Group N.V. — All Filings
130 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
424B4
6-K
6-K/A
8-A12B
CERT
CORRESP
DRS
EFFECT
F-1
F-1/A
F-6
S-8
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | 6-K | 0001828316-26-000012 | Mar 27, 2026 | — |
| 6-K | 6-K | 0001828316-26-000010 | Mar 24, 2026 | — |
| 6-K | 6-K | 0001828316-26-000008 | Mar 12, 2026 | — |
| 6-K | 6-K | 0001828316-26-000006 | Feb 3, 2026 | — |
| 6-K | 6-K | 0001828316-26-000004 | Feb 2, 2026 | Feb 1, 2026 |
| 6-K | 6-K | 0001828316-26-000002 | Jan 8, 2026 | — |
| 6-K | 6-K | 0001828316-25-000049 | Nov 6, 2025 | — |
| 6-K | 6-K | 0001828316-25-000047 | Oct 22, 2025 | Oct 20, 2025 |
| 6-K | 6-K | 0001828316-25-000045 | Oct 6, 2025 | — |
| 6-K | 6-K | 0001828316-25-000043 | Oct 1, 2025 | — |
| 6-K | 6-K | 0001828316-25-000041 | Sep 10, 2025 | — |
| 6-K | 6-K | 0001828316-25-000039 | Sep 2, 2025 | — |
| 6-K | 6-K | 0001828316-25-000034 | Jul 31, 2025 | — |
| 6-K | 6-K | 0001828316-25-000031 | Jun 24, 2025 | — |
| 6-K | 6-K | 0001828316-25-000029 | Jun 11, 2025 | — |
| 6-K | 6-K | 0001828316-25-000027 | May 8, 2025 | — |
| 6-K | 6-K | 0001828316-25-000025 | Apr 30, 2025 | — |
| 6-K | 6-K | 0001828316-25-000023 | Apr 25, 2025 | — |
| 6-K | 6-K | 0001828316-25-000021 | Apr 23, 2025 | — |
| 6-K | 6-K | 0001828316-25-000019 | Apr 3, 2025 | — |
| 20-F | 20-F | 0001828316-25-000017 | Apr 3, 2025 | Dec 31, 2024 |
| 6-K | 6-K | 0001828316-25-000014 | Mar 20, 2025 | — |
| 6-K | 6-K | 0001828316-25-000012 | Mar 13, 2025 | — |
| 6-K | 6-K | 0001828316-25-000010 | Mar 4, 2025 | — |
| 6-K | 6-K | 0001828316-25-000008 | Feb 20, 2025 | — |
| 6-K | 6-K | 0001828316-25-000006 | Feb 7, 2025 | — |
| 6-K | 6-K | 0001828316-25-000004 | Jan 21, 2025 | — |
| 6-K | 6-K | 0001828316-25-000002 | Jan 21, 2025 | — |
| 6-K | 6-K | 0001828316-24-000039 | Dec 16, 2024 | Dec 15, 2024 |
| 6-K | 6-K | 0001828316-24-000037 | Dec 11, 2024 | — |
| SC 13G/A | PHARMING GROUP N.V. | 0000902664-24-006488 | Nov 14, 2024 | — |
| 6-K | 6-K | 0001828316-24-000035 | Oct 24, 2024 | — |
| 6-K | 6-K | 0001828316-24-000033 | Oct 10, 2024 | — |
| 6-K | 6-K | 0001828316-24-000031 | Sep 26, 2024 | — |
| 6-K | 6-K | 0001828316-24-000029 | Aug 1, 2024 | — |
| 6-K | 6-K | 0001828316-24-000027 | May 30, 2024 | — |
| 6-K | 6-K | 0001828316-24-000025 | May 21, 2024 | — |
| 6-K | 6-K | 0001828316-24-000022 | May 15, 2024 | — |
| 6-K | 6-K | 0001828316-24-000020 | May 8, 2024 | — |
| 6-K | 6-K | 0001828316-24-000016 | Apr 25, 2024 | — |
| 6-K | 6-K | 0001828316-24-000014 | Apr 24, 2024 | — |
| 6-K | 6-K | 0001828316-24-000012 | Apr 8, 2024 | — |
| 6-K | 6-K | 0001828316-24-000010 | Apr 4, 2024 | — |
| 20-F | 20-F | 0001828316-24-000008 | Apr 4, 2024 | Dec 31, 2023 |
| 6-K | 6-K | 0001828316-24-000003 | Mar 14, 2024 | — |
| SC 13G | PHARMING GROUP N.V. | 0000902664-24-001537 | Feb 14, 2024 | — |
| 6-K | 6-K | 0001628280-24-000782 | Jan 8, 2024 | — |
| 6-K | 6-K | 0001628280-23-041636 | Dec 15, 2023 | Dec 13, 2023 |
| 6-K | 6-K | 0001628280-23-038453 | Nov 13, 2023 | Nov 10, 2023 |
| 6-K | 6-K | 0001628280-23-035203 | Oct 26, 2023 | — |